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Background: Community-genotype methicillin-resistant Staphylococcus aureus (CG-MRSA) clones are a global
concern due to their resistance and increased virulence and their ability to cause infections both hospitalized
patients and healthy people in the community. Here, we characterize 32 isolates of a new CG-MRSA clone. These
isolates were identified in four cities in Colombia, South America.
Methods: The isolates were recovered from four different epidemiological and prospective studies that were conducted
in several regions of Colombia. Molecular characterizations included multilocus sequence typing; pulsed-field gel
electrophoresis; SCCmec, agr and spa typing; and whole-genome sequencing.
Results: All isolates belonged to ST923 (clonal complex 8), harbouring SCCmec IVa and a spa type t1635 and lacking
an arginine catabolism mobile element. The isolates were classified as COL923, were resistant to at least one non-beta-
lactam antibiotic, and exhibited high frequencies (>60%) of resistance to macrolides and tetracycline. Using whole-
genome sequencing, we found that this new clone harbours novel prophage 3 and beta-island structures and a slightly
different pathogenicity island 5. Moreover, isolates belonging to the COL923 clone are grouped in a different clade than
USA300 and USA300-LV.
Conclusion: Our results show the emergence and spread of the COL923 clone in different cities in Colombia. This clone
is resistant to several antibiotics and possesses new structures in its mobile genetic elements.
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The emergence, dissemination and establishment of
community-genotype methicillin-resistant Staphylococcus
aureus (CG-MRSA) clones is a global concern due to their
increased virulence and their enhanced ability to cause
infections in healthy people compared with hospital-
genotype MRSA (HG-MRSA) clones. In addition, the
frequency of CG-MRSA clones has increased among
MRSA infections in hospitalized patients in several coun-
tries worldwide [1–4], which implies the replacement of
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resistance to non-beta-lactam antibiotics. USA300 is a
CG-MRSA pandemic clone that is circulating in North
America [1] but has also been reported on every other
continent, including in countries such as Denmark, Spain,
France, Italy, Norway, Austria, the United Kingdom,
Germany, Japan, Korea, Singapore and Australia [5–8].
This distribution of this clone demonstrates its ability to
spread. Since 2004, a CG-MRSA clone that is genetically
related to USA300 has been found to cause infections in
adults and children in Colombia and several other South
American countries [6, 9, 10]. In contrast to USA300, this
variant harbours SCCmec IVc (3.1.2) element but lacks an
arginine catabolism mobile element (ACME). In recent
years, the frequency of this MRSA-IVc clone has increasedle is distributed under the terms of the Creative Commons Attribution 4.0
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hospitalized patients, replacing traditional HG-MRSA
clones (e.g., Chilean and Brazilian clones) [11, 12]. We re-
cently reported the detection of eight isolates belonging to
a new CG-MRSA clone that have caused paediatric infec-
tions in Bogota, Colombia [13]. These isolates were found
to possess SCCmec IVa and a spa type t1635; to belonged
to the ST923 (a single-locus variant of ST8); to possess an
SmaI-restriction pulsed-field gel electrophoresis (PFGE)
pulsotype that is not related to that of the USA300 clone
(>6 bands of difference); and to lack an ACME, which is
frequently found in the USA300 clone. To determinate
whether this new clone is circulating in other areas of
Colombia, we conducted an active search for this clone
and performed a genomic characterization. In this study,
we show that this new CG-MRSA clone (named COL923
by our group) circulates in at least four regions of
Colombia and possesses new clone-specific molecular
characteristics.
Methods
Bacterial isolate collection and identification
A total of 32 CG-MRSA isolates (containing SCCmec
type IV and/or possessing the gene lukS/F-PV, seq, sek or
bsaB) belonging to the new clone COL923 (SCCmec
IVa, spa type t1635 and ST923) were identified in four
different studies (Additional file 1: Table S1). In the first
study, 430 S. aureus isolates were prospectively and sys-
tematically recovered from infections in paediatric pa-
tients (<18 years old) at a hospital in Cartagena, which is
a city on the Caribbean coast. Nineteen of the MRSA
isolates were related to COL923 (one isolate per patient).
In the second study, MRSA nasal colonization was in-
vestigated in 2867 healthy adult individuals (>18 years
old) living in 10 regions that are geographically distant
from Colombia. Of the isolates obtained, three isolates
from two different regions were related to COL923. In
the third study, MRSA nasal colonization was investi-
gated in 150 healthy children (<5 years old) in Monteria,
which is a city in northwest Colombia. Of the isolates
obtained, six isolates were related to COL923. Finally, in
the fourth study, MRSA nasal colonization was evalu-
ated in 205 healthy children (5 to 14 years old) in Carta-
gena, and four CG-MRSA isolates were found to belong
to the new clone.
Antimicrobial susceptibility testing
The profile of susceptibility to 12 antibiotics (oxacillin,
gentamicin, rifampicin, erythromycin, ciprofloxacin,
vancomycin, linezolid, tetracycline, clindamycin, chlor-
amphenicol, trimethoprim and sulfamethoxazole) was
determined for each of the isolates using the agar dilu-
tion method. The results were interpreted according to
the 2015 guidelines of the Clinical and LaboratoryStandards Institute (CLSI). Inducible clindamycin resist-
ance was also determined using the D-test.
Molecular characterization and establishment of genetic
relatedness of isolates
The SCCmec type and subtype were established for each
clone using multiplex PCR, as previously described [14].
The lukS/F-PV, etb, eta, hlg, sea, seb, sec, seg, seh, sei, sej,
sek, sel, sem, sen, seo, sep and seq genes were also ana-
lysed using PCR [15]. In addition, the presence of the
blaZ, tetK, tetM, ermA, ermB, ermC, msrA, mph and
mefA genes was evaluated in all isolates. Genetic related-
ness between the isolates was determined by PFGE. The
obtained pulsotypes were interpreted according to the
percentage of similarity and the criteria proposed by
Tenover and colleagues [16]. The agr group, spa type
and multilocus sequence typing were determined as pre-
viously reported [17].
Detection of mobile genetic elements (MGEs) and
genome sequencing of new CG-MRSA clone
The presence or absence of the most important MGEs
and genomic islands (GIs) was evaluated using different
PCR strategies (Additional file 2: Figure S1). For the gen-
ome sequencing analysis, isolates were selected as fol-
lows: for the COL923 clone, two representative isolates
were selected for each of the two main PFGE pulsotypes
(isolates 5sau489 and 17sau368, belonging to the first
PFGE pulsotype (Fig. 1), and isolates 5sau410 and
17sau58, belonging to the second PFGE pulsotype
(Fig. 1)). In addition, Col131 was selected because it was
the first isolate related to the COL923 clone that was
identified in Colombia. For the USA300-LV clone (the
most frequent CG-MRSA clone in Colombia), one rep-
resentative isolate was selected for each of the four most
frequent PFGE pulsotypes (i.e., 17sau599, 5sau003/
17sau366, 17sau193 and 17sau391). Total DNA was ex-
tracted from the 10 MRSA clinical isolates using the
PureLink® Genomic DNA Mini Kit from Thermo Fisher.
The DNA was used to prepare multiplexed total DNA li-
braries using the Nextera XT Dual Index Sequencing
Primer Kit (Illumina, Inc.) and the KAPA Library Ampli-
fication Kit (Kapa Biosystems). The multiplexed libraries
were pooled and sequenced by paired-end sequencing
using the Illumina MiSeq (2x300 cycles) and HiSeq
(2x101 cycles) platforms. The libraries were assembled
using SOAPdenovo2 V2.04-r240, with kmer values of 63
and 127 for HiSeq and MiSeq, respectively. The basic as-
sembly statistics are shown in Additional file 3: Table S2.
The reads were also mapped to the USA300-FPR3757
genome using SHRiMP 2.2.3 and were then compared
and visualized using BRIG software [18, 19]. The genetic
relatedness of the sequenced isolates was established
using phylogenetic analysis. To build a phylogenetic
Fig. 1 Genetic relatedness among isolates belonged to the COL923 clone identified in Colombia. The isolates underlined correspond to the
isolates identified previously. USA300-0114-FPR3757 and CHL93 (Chilean clone) strains were used as standards. PFGE patterns were considered
different when they showed a similarity lower than 75% (broken line). Shaded region indicates the two more frequent pulsotypes. a. Type of isolate:
I = infection, C = Colonization. b. OXA = oxacillin, TET = tetracycline, ERY = erythromycin, GEN = gentamicin, CIP = ciprofloxacin, CLI = clindamycin
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17sau368, 17sau391, 17sau58, 17sau599, 5sau003,
5sau410, 5sau489 and Col131) and reference (i.e.,
USA300 and NCTC8325) genomes were annotated
using Prokka [20] and an alignment was created for
2288 concatenated core genes (genes with ≥99% nu-
cleotide identity that were present in all genomes)
using Roary [21] and PRANK [22]. Poorly aligned po-
sitions and divergent regions were eliminated using
Gblocks [23]. Finally, the phylogenetic tree was cre-
ated using RAxML version 8.2.9 [24] by running 1000
bootstrap replicates under the generalized time-
reversible model (GTRCAT). Finally, a consensus tree
was plotted using Dendroscope [25]. Branch lengths
are expressed in units of changes/nucleotide position(scale bar). The NCTC8325 strain was included as an
outgroup control (GenBank ID: NC_007795.1). Differ-
ent MGEs were identified from the mapping analysis
and then annotated using the RAST server [26].
Results
Among the 32 CG-MRSA isolates belonging to the
COL923 clone that were analysed, 19 were recovered
from paediatric infections, and 13 were recovered from
nasal samples from healthy youths and children. Among
the 19 infection isolates, one was identified in 2009; two,
in 2010; nine, in 2011; and seven, in 2012. The main
clinical diagnosis was skin or soft-tissue infection (10
cases). Four patients developed septic shock, and of
these, one also developed pneumonia (Table 1). Eighteen
Table 1 Demographic and clinical characteristics of paediatric
patients with MRSA infections
Demographic data and clinical
characteristics
All subjects (n = 19)
n (%)
Age (years) (range) 8.3 (0.17–14)
Age distribution
Newborn 0 (0.0)
Infants 1 (5.3)
Pre-school age 4 (21.1)
School age 7 (36.8)
Adolescents 7 (36.8)
Male sex, % 12 (63.0)
Year of recovery (time in months)a
2009 (3) 1 (5.3)
2010 (12) 2 (10.5)
2011 (12) 9 (47.4)
2012 (6) 7 (36.8)
Admission Site
Emergency room 19 (100.0)
Clinical diagnosis
SSTIb 10 (43.8)
Osteoarticular infection 5 (26.0)
Pneumonia 1 (5.6)
Septic Shock 3 (2.5)
Onset time of symptoms (mean, SDc), days 17.4 (20.0)
Hospital managementd
Hospitalized- drainage 15 (69.1)
PICU 4 (24.1)
Empirical antimicrobial therapye
CLI 13 (68.4)
OXA 2 (10.5)
CLI/RIF 2 (10.5)
RIF 1 (5.3)
CLI/RIF/VAN 1 (5.3)
Definitive antimicrobial therapye
SXT 11 (57.9)
CLI/RIF 3 (15.8)
OXA 1 (5.3)
RIF 1 (5.3)
CLI 1 (5.3)
CLI/RIF/VAN 1 (5.3)
VAN/LZD/SXT 1 (5.3)
Clinical outcome
Improvement 19 (100.0)
aThe collection time of the isolates was between October 2009 and June 2012
bSSTI Skin and soft tissue infection
cSD standard deviation
dPICU paediatric intensive care unit
eCLI clindamycin, OXA oxacillin, RIF rifampicin, SXT trimethoprim-sulfamethoxazole,
VAN vancomycin, LZD linezolid
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with active antimicrobials, and one was treated with oxa-
cillin. Thirteen patients (68.4%) were additionally man-
aged with incision and drainage with full recovery
observed in all 13 cases. Four patients (21.05%) required
a paediatric intensive care unit stay because of the sever-
ity of their infections. All (100%) infections were identi-
fied within the first 48 h of hospital admission in
children without healthcare-associated risk factors who
entered the hospital through the emergency department
(i.e., community-onset MRSA infections).
In contrast, the 13 MRSA nasal colonization isolates
were identified and recovered from healthy people living
in Medellin, Cartagena, Monteria and Fusagasuga, which
are four cities both distant from each other and distant
from Bogota and Villavicencio, where the COL923 strain
was first reported. The fact that we did not find any epi-
demiological link among the people harbouring this
clone suggested that this CG-MRSA clone was already
circulating in several regions of the country.
Antimicrobial resistance profiles and resistance
mechanisms
All isolates were susceptible to vancomycin, linezolid, clin-
damycin, gentamicin, rifampicin, chloramphenicol and tri-
methoprim/sulfamethoxazole. However, the minimal
inhibitory concentration (MIC) for vancomycin was 1 mg/
L. Of the 32 COL923 isolates, 30 (93.8%), 21 (65.6%) and
12 (37.5%) were resistant to erythromycin, tetracycline
and ciprofloxacin, respectively (Table 2). Additionally, all
isolates were resistant to at least one non-beta-lactam
antibiotic. The most frequent multiresistance profiles con-
sisted of erythromycin-tetracycline resistance (40.6%) or
erythromycin-tetracycline-ciprofloxacin resistance (25.0%)
(Table 2). The blaZ gene was detected in all of the isolates.
All erythromycin-resistant isolates (30) presented an M
phenotype and harboured the msrA and mphC genes. The
21 isolates that were resistant to tetracycline harboured
the tetK gene. The blaZ, tetK, msrA and mphC genes were
localized in contigs that did not map to the USA300-
FPR3757 genome, suggesting the possibility of transmis-
sion by plasmids, although this needs to be confirmed in
future work.
Molecular characteristics and genetic relatedness of
isolates
The molecular characterization of the 32 CG-MRSA iso-
lates demonstrated that they all harboured SCCmec IVa
(IV.1.1.1), were of spa type t1635 (YHGFMBO) and pre-
sented a 54-bp insertion in the sausa300_0808 gene in S.
aureus pathogenicity island 5 (SaPI5). These same fea-
tures were previously found in the COL923 isolates re-
covered from paediatric infections in Bogota, Colombia
[13]. All isolates harboured the sek and seq genes within
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isolates. An ACME was not detected in any of the iso-
lates. The PFGE analysis of the 32 isolates revealed the
presence of 10 different pulsotypes (the N1 to N3, N5 to
N9, N12 and N13 pulsotypes, as shown in Fig. 1). The
N1 and N2 pulsotypes were the most frequent, found in
9 (28.1%) and 7 (21.9%) isolates, respectively (Table 2).
All 32 isolates included in this study showed similarities
greater than 80% with respect to the isolates previously
recovered in Bogota [12] (Fig. 1). Finally, all isolates
belonged to agr group I and the sequence type 923.
Detection of MGEs, GIs and genome comparison
The assembly statistics for the sequenced genomes are
shown in Additional file 3: Table S2. The genomic map-
ping of the COL923 clone revealed certain differences
with respect to the USA300-FPR3757 and USA300-LV
clones (Fig. 2). These differences were mainly due to
changes in the MGEs (e.g., changes in the prophage 3,
beta-island, and SCCmec J3 regions and the absence of
ISsau5) in addition to single-nucleotide polymorphisms
in the core genome. It is also important to highlight that
the beta-island (υSaβ) was smaller in the COL923 clone
(13,980 bp) than in the USA300-FPR3757 and USA300-
LV (37,590 bp) clones, displaying a truncated structure.
PCR analysis showed that all isolates (except Col131)
possessed this truncated beta-island (υSaβ) structureTable 2 Antimicrobial resistance and molecular characteristics of MR
Characteristics of
isolates
All isolates (n = 32)
n (%)
Antimicrobial resistancea
ERY 30 (93.8)
TET 21 (65.6)
CIP 12 (37.5)
Multiple antibiotics resistance profiles
OXA-ERY-TET 13 (40.6)
OXA-ERY-TET-CIP 8 (25.0)
OXA-ERY 7 (21.9)
OXA-CIP 2 (6.3)
OXA-ERY-CIP 2 (6.3)
Only OXAb 0 (0.0)
Main PFGE pulsotypec
N1 9 (28.1)
N2 7 (21.9)
N3 5 (15.6)
N5 2 (6.3)
N6 2 (6.3)
aOXA oxacillin, TET tetracycline, ERY erythromycin, GEN gentamicin, CIP ciprofloxacin
bSusceptibility to non-B-lactam antibiotics
cN4 pulsotype was assigned to isolates recovered from Bogota (Fig. 1)(Fig. 2a and Fig. 3b and c). All isolates harboured the sak
gene (a marker of prophage 3), and genome sequencing
confirmed the presence of prophage 3 (ϕSA3) but indi-
cated that it possessed a new genetic structure that best
matched the NCTC8325 strain (63.4% identity) (Fig. 3a).
However, this prophage 3 (ϕSA3) shared low sequence
identity with the USA300-FPR3757 (38.4%) and N315
(39.6%) prophage 3 (ϕSA3). Additionally, the genome se-
quencing analysis of 5sau489 revealed two DNA inser-
tions in the SCCmec J3 region that were not present in
USA300-FPR3757 (Fig. 3d). The first insertion (578 bp)
harboured an open reading frame (ORF) that encoded a
putative transposase, which had previously been re-
ported in another CG-MRSA-ST72-IVa strain that was
identified in South Korea [27]. PCR analysis showed that
all isolates (including the 32 isolates described in this
study and 9 isolates identified previously) contained two
DNA insertions in the J3 region of SCCmec (Fig. 3e).
These findings show that the COL923 clone possesses
SCCmec IVa that is not identical to that in USA300.
The genetic structure of νSaα in the isolates described
in this study was the same as that reported for the
USA300 clone [28]. A maximum-likelihood phylogenetic
analysis of the core genomes showed that the isolates
could be segregated into two distinct clades (Fig. 2c).
Clade 1 consisted of isolates belonging to the USA300-
LV clone (ST8-IVc), while clade 2 consisted of isolatesSA isolates belonging to the COL923 clone
Infection (n = 19) Colonization (n = 13)
n (%) n (%)
17 (89.5) 13 (100.0)
11 (57.9) 10 (76.9)
10 (52.6) 2 (15.4)
4 (21.1) 9 (69.2)
7 (36.8) 1 (7.7)
5 (26.3) 2 (15.4)
2 (10.5) 0 (0.0)
1 (5.3) 1 (7.7)
0 (0.0) 0 (0.0)
8 (42.1) 1 (7.7)
1 (5.3) 6 (46.2)
2 (10.5) 3 (23.1)
2 (10.5) 0 (0.0)
1 (5.3) 1 (7.7)
, CLI clindamycin
Fig. 2 Genomic comparison of COL923, USA300-LV and USA300-FPR3757 clones. a Read mapping coverage of sequencing reads of COL923 clone
(5sau489 isolate as representative for the most frequent pulsotype, blue circle) and USA300-LV (5sau003, orange circle), compared to the USA300-FPR3757
genome (GenBank number: CP000255.1), the black most inner ring. The outer circle (alternating red-blue) represents the USA300 SmaI fragments
(responsible for the PFGE pulsotype). Black and grey fragments represent fragments that change in the COL923 clone, by loss of the SmaI recognition sites.
Matches with less than 80% of nucleotide identity or regions without match to the reference genome appear as blank in each ring. The image was
prepared using BRIG. b SmaI-restriction PFGE pulsotypes of USA300 and COL923 (5sau489 isolate) clones. Black arrows show the two new fragments
in the COL923 clone which were produced for the loss of the SmaI cuts between the fragments 12 and 13, and fragments 15 and 16 (black and grey
fragments in figure a). c Maximun likelihood phylogenetic analysis using core genomes from representative isolates belonging to the COL923 clone
(clade 2) and USA300-LV (clade 1). The USA300 clone grouped in a different clade more related to the USA300-LV
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USA300 clone was not part of any clade; nevertheless, it
was more closely related to the isolates in the USA300-
LV clade. Taken together, these data strengthen the idea
that the COL923 clone is genetically different with re-
spect to the USA300 and USA300-LV clones, in addition
to the differences observed in MGEs.
Discussion
The extraordinary genetic success of CG-MRSA clones
is now well known, and we have observed that its fre-
quency has increased during the last two decades, first
in the community and then in the hospital setting, in
several countries around the world. In Colombia, severalgenetic and molecular analyses have shown that the
most prevalent CG-MRSA clone (USA300-LV) possesses
certain characteristics that are similar to those of the
USA300 pandemic clone. However, the Colombian CG-
MRSA clone harbours a different SCCmec (IVc or
IV.3.1.2) and, interestingly, does not possess an ACME
[6, 11, 29–31]. Between 2008 and 2011, the prevalence
of this clone was reported to comprise 70% and 90% of
MRSA infections in adults and paediatric patients, re-
spectively [6, 11, 30], in several Colombian cities. How-
ever, in 2010, we identified eight CG-MRSA isolates
with different molecular and genetic characteristics com-
pared to the USA300-LV clone but with similarity to the
COL923 clone [12, 13]. Our data showed that the
Fig. 3 Novel structures in the mobile genetic elements in the COL923 clone. Schematic diagrams of the prophage 3, Beta Island and SCCmec J3
region. a Prophage 3 structures identified in COL923 (5sau489), N315 (GenBank number: BA000018.3), NCTC8325 (GenBank number: CP000253.1)
and USA300-FPR3757 (GenBank number: CP000255.1). b Beta island structures identified in COL923 (5sau489) and USA300-FPR3757 (GenBank
number: CP000255.1). The beta island size in COL923 (5sau489) was 13,980bp. c PCR amplification of a partial region of the beta island in COL923
(5sau489, 20sau42 and Col131 isolates) and USA300-FPR3757. d Structure of the SCCmec J3 regions identified in COL923 (5sau489) and USA300-
FPR3757. e PCR amplification of the partial J3 SCCmec region that contains the putative ORF encoding for a transposase (tn) in COL923 (5sau489,
20sau42 and Col131 isolates). Shaded regions represent sequences with >95% of nucleotide identity. SmaI: restriction site for the SmaI enzyme.
Black arrows represent the ORFs localized upstream and downstream of the mobile genetic elements and genomic islands. Primers used in PCR
amplifications are showed as black triangles
Escobar-Perez et al. BMC Infectious Diseases  (2017) 17:108 Page 7 of 10COL923 (CG-MRSA-IVa-ST923) clone had also been
causing infections in children in other regions of
Colombia (outside Bogota) since 2009. This new clone
was identified in five distant geographic areas, which
suggests that it was already circulating in several regions
of our country and that its emergence represents a
dissemination event, and not an epidemic event in
one city [11, 29, 32].
In addition, whole-genome sequencing analysis re-
vealed unique characteristics in both the MGE and the
core genome of this new CG-MRSA clone. With respect
to SCCmec, certain variations were found in its J3 region
(Figs. 2 and 3d). For example, a 578-bp insertion was
identified that has also been recently reported in
SCCmec IVa element harboured in an ST72 (CC8,triple-locus variant of ST8) clinical isolate that caused a
community-onset infection [27]. This particular region
contains an ORF that encodes a putative transposase.
Although the SCCmec IVa element in the COL923 clone
still has high nucleotide identity (>98%) with the
SCCmec IVa element in the USA300 clone, our results
show that it has also acquired certain foreign DNA frag-
ments [12, 13]. These results reinforce the idea that the
new variant (COL923) has gained DNA fragments and
support the importance of further studies aimed at in-
creasing our understanding of this process.
The novel results of the present study include the
identification of new prophage 3 (ϕSA3) and beta-island
(υSaβ) structures in the COL923 clone. To our know-
ledge, these structures have not been previously
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3 has low genetic relatedness to the prophage 3 that was
previously identified in the USA300 clone. Based on its
structure and size, this new prophage can be classified
into the Siphoviridae family, and it combines parts of
other prophages into a mosaic structure. Thus, we could
hypothesize that it originated during a series of events
that involved recombination among the functional mod-
ules of different prophage 3 types, a process that has
been previously reported in Siphoviridae prophages [33].
The insertion of this new prophage 3 and a truncated
beta-island caused the loss of two SmaI restriction sites
in the chromosome of the new clone, leading to a
change in the PFGE pulsotype (Fig. 2).
In 2006, Alvarez et al. reported recovering CG-MRSA
isolates (Col131) from an infection in an adult patient in
2004 [9, 34], Subsequent molecular and genetic analyses
showed that this Col131 isolate harboured SCCmec IVa.
The molecular analysis of the Col131 isolate that we per-
formed showed that it shared molecular characteristics
with the new COL923 clone (ST923, spa type t1635,
sausa300_0808-variant gene, prophage 3, SaPI5 and J3-
SCCmec structure) but had a different PFGE pulsotype
(Fig. 1). Interestingly, since 2004, the USA300-LV clone
has shown increasing frequency in MRSA infections,
whereas the COL923 clone has shown a very low fre-
quency. These findings suggest two possible hypotheses.
First, the Col131 isolate, after acquiring SCCmec IVa,
may have undergone several genetic changes that re-
sulted in environmental advantages that gave rise to the
COL923 isolates identified since 2009. Second, certain
ST923 methicillin-sensitive S. aureus isolates with simi-
lar molecular characteristics and genetic relatedness to
the Col131 isolate may have acquired the same SCCmec
IVa during different events.
It is important to highlight that among the COL923
isolates identified here, four were resistant to the non-beta-
lactam antibiotics ciprofloxacin, erythromycin and tetra-
cycline. The last two types of resistance are associated with
the msrA, mphC and tetK genes, which are possibly carried
by plasmids (these were not mapped in the reference chro-
mosomes), suggesting that plasmids are mobilizing among
CG-MRSA clones present within the community in
Colombia. We hypothesize that both selective pressure due
to the overuse of antibiotics and the unnatural accumula-
tion of certain substances in the community have filtered
the local S. aureus population to favour the new variant,
which likely has better fitness because of its msrA- or tetK-
positive plasmid. In comparison with the USA300 and
USA300-LV clones circulating in our region, the COL923
clone displays a broader resistance range and an MIC to
vancomycin of 1 mg/L, even outside the hospital setting.
The rise in the frequency of this clone is therefore a pos-
sible challenge to the health system.Conclusion
Our data demonstrate that a new CG-MRSA COL923
clone is circulating in different regions of Colombia, ra-
ther than being confined to a single city. Additionally,
this clone possesses new genetic structures that have not
been previously reported that differentiate it from the
USA300-LV and USA300 clones. The COL923 clone is a
new CG-MRSA clone that is causing infections in people
in the community and that is also having an impact
within the health system. It has been frequently observed
that although many clones possess the ability to acquire
the same SCCmec, only a few prevail, with certain clones
predominating in their respective geographic niches [35].
This finding suggests that specific genetic determinants
govern the predominance of different clones in different
regions of the globe. Thus, it is necessary to continue sur-
veillance studies in both the community and hospitals to
assess the clinical, economic and social impacts of the dis-
semination of this new CG-MRSA clone.
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